A critical advance in cancer investigation is emerging with the use of mini-antibodies to reactivate mutated p53. This vital tumor inhibitor protein is frequently inactivated in many kinds of tumors, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research